Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer

Diseases of the Esophagus

Volumn 24, Issue 3, 2011, Pages 182-188

  Sun, Zhi Gang ^a   Wang, Zhou ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Esophageal squamous cell cancer; Lymph node metastasis; Mucin1

Indexed keywords

MUCIN 1;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCIN-1; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 79954471782     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01125.x     Document Type: Article

References (19)

1. Zhang D W, Cheng G Y, Huang G J etal. Operable squamous esophageal carcinoma: current results from the East. World J Surg 1994; 18: 347-54.
2. Watson A. Operable squamous esophageal carcinoma: current results from the West. World J Surg 1994; 18: 361-6.
3. Visbal A L, Allen M S, Miller D L, Deschamps C, Trastek V F, Pairolero P C. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 2001; 71: 1803-8.
4. Eloubeidi M A, Desmond R, Arguedas M R, Reed C E, Wilcox C M. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434-43.
5. Hosch S, Raus J, Scheunemann P etal. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer. Cancer Res 2000; 60: 6836-40.
6. Godfrey T E, Raja S, Finkelstein S D, Gooding W E, Kelly L A, Luketich J D. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res 2001; 7: 4041-8.
7. Ho S B, Niehans G A, Lyftogt C etal. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993; 53: 641-51.
8. Wang Z, Yin H, Zhang L, Lan X, Li H. Gene diagnosis and prognosis of mediastinal lymph node occult micrometastasis in non-small cell lung carcinoma. Zhonghua Zhong Liu Za Zhi 2002; 24: 247-9.
9. Korst R J, Rusch V W, Venkatraman E etal. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998; 115: 660-70.
10. Chen G, Wang Z, Liu X Y, Liu F Y. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor Lewis esophagectomy. World J Surg 2007; 31: 1107-14.
11. Li S H, Wang Z, Liu X Y etal. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today 2007; 37: 1047-52.
12. Parkin D M. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-43.
13. Li S H, Wang Z, Liu X Y. Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer. World J Surg 2009; 33: 1876-81.
14. Raja S, Luketich J D, Kelly L A, Gooding W E, Finkelstein S D, Godfrey T E. Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg 2002; 123: 475-82.
15. Kato H, Tachimori Y, Watanabe H, Igaki H, Nakanishi Y, Ochiai A. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection. J Surg Oncol 1996; 61: 267-72.
16. Gusterson B. Are micrometastase clinically relevant? Br J Hosp Med 1992; 47: 247-8.
17. Jiao X, Krasna M J. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 2002; 74: 278-84.
18. Salerno C T, Frizelle S, Niehans G A etal. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction. Chest 1998; 113: 1526-32.
19. Chen G, Wang Z, Liu X Y, Liu F Y. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Ann Thorac Surg 2009; 87: 1697-702.